Exchange: NASDAQ·Updated 07:34 PM EDT
Latest Earnings Results: Q2 '26

Reported: Jul 29

Estimated EPS

$0.48

Reported EPS

$0.56

Surprise

+16.55%

Estimated Rev

$417.54M

Reported Rev

$418.76M

Surprise

+0.29%

$IART Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.06 up 100.95% YoY • Reported revenue of $418.76M up 0.76% YoY • Integra LifeSciences updates its 2026 reported revenue guidance range to $1.654 billion to $1.695 billion, while reaffirming full-year organic revenue growth of 0.8% to 3.3% and adjusted EPS of $2.40 to $2.50.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.56
--
--
N/A
Q2 '26
$0.48
$0.56
16.55%
BEAT
Q1 '26
$0.40
$0.54
33.35%
BEAT
Q4 '25
$0.80
$0.83
3.73%
BEAT
Q3 '25
$0.43
$0.54
24.31%
BEAT

Advertisement|Remove ads.